Wesper Journal

Did you know that sleep disorders, like sleep apnea, can significantly impact your health if not diagnosed and treated properly? Understanding how to diagnose these conditions is crucial for effective treatment. This article explores two main methods for diagnosing sleep...
Continue reading

Sleep maintenance insomnia is often caused by factors such as hormonal changes, lifestyle habits, and anxiety, making it difficult to fall back asleep after nighttime awakenings. Identifying personal triggers and implementing strategies like maintaining a consistent sleep schedule can help...
Continue reading

Zepbound (tirzepatide) has received FDA approval for the treatment of obstructive sleep apnea, now included in Medicare coverage to help manage the condition alongside obesity. This approval marks a shift towards a holistic approach, combining medication with real-time monitoring for...
Continue reading

GLP-1 therapies, such as Zepbound (tirzepatide), address obstructive sleep apnea by aiding weight management, thereby reducing airway pressure and improving respiratory health. Wesper's wearable technology enhances treatment by providing continuous monitoring, allowing for timely adjustments to therapy plans. FDA’s Landmark...
Continue reading

In primary care, the integration of GLP-1 medications and Wesper's sleep technology offers a holistic approach that improves patient outcomes by enhancing metabolic health and streamlining sleep disorder management. This synergy revolutionizes healthcare delivery, promoting efficient care coordination and personalized...
Continue reading